Quality of life in cervical dystonia after treatment with botulinum toxin a: A 24-week prospective study
© 2017 Kongsaengdao et al. Objective: This study aimed to identify possible improvements in disease-specific health-related quality of life (HRQoL) after multiple injections of botulinum toxin A over 24 weeks in Thai cervical dystonia (CD) patients. Materials and methods: A 24-week prospective study...
Saved in:
Main Authors: | , , |
---|---|
Format: | Journal |
Published: |
2017
|
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85010280708&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/40837 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
id |
th-cmuir.6653943832-40837 |
---|---|
record_format |
dspace |
spelling |
th-cmuir.6653943832-408372017-09-28T04:11:43Z Quality of life in cervical dystonia after treatment with botulinum toxin a: A 24-week prospective study Kongsaengdao S. Maneeton B. Maneeton N. © 2017 Kongsaengdao et al. Objective: This study aimed to identify possible improvements in disease-specific health-related quality of life (HRQoL) after multiple injections of botulinum toxin A over 24 weeks in Thai cervical dystonia (CD) patients. Materials and methods: A 24-week prospective study comparing HRQoL of Thai CD patients before and after multiple injections of botulinum toxin A at 3-month intervals was performed. Disease-specific HRQoL was assessed by using the Cervical Dystonia Impact Profile-58 questionnaire (CDIP-58) and the Craniocervical Dystonia Questionnaire-24 (CDQ-24). General HRQoL was assessed by using the Medical Outcomes’ 36-Item Short Form Health Survey (SF-36) and the EuroQoL 5-dimension questionnaire (EQ-5D). All the assessments were performed before and after the 24-week treatment period. Results: A total of 20 CD patients were enrolled in this study from April to December 2011. CDIP-58 and CDQ-24 scores, which assess disease-specific HRQoL, showed a significant improvement after 24 weeks of treatment by botulinum toxin A (P < 0.001). However, EQ-5D and SF-36 scores, which assess general HRQoL, showed no significant improvement after the treatment (P > 0.05). Conclusion: CD patients’ disease-specific HRQoL improved after being treated with multiple botulinum toxin A injections. However, general HRQoL was not improved. 2017-09-28T04:11:43Z 2017-09-28T04:11:43Z Journal 11766328 2-s2.0-85010280708 10.2147/NDT.S116325 https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85010280708&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/40837 |
institution |
Chiang Mai University |
building |
Chiang Mai University Library |
country |
Thailand |
collection |
CMU Intellectual Repository |
description |
© 2017 Kongsaengdao et al. Objective: This study aimed to identify possible improvements in disease-specific health-related quality of life (HRQoL) after multiple injections of botulinum toxin A over 24 weeks in Thai cervical dystonia (CD) patients. Materials and methods: A 24-week prospective study comparing HRQoL of Thai CD patients before and after multiple injections of botulinum toxin A at 3-month intervals was performed. Disease-specific HRQoL was assessed by using the Cervical Dystonia Impact Profile-58 questionnaire (CDIP-58) and the Craniocervical Dystonia Questionnaire-24 (CDQ-24). General HRQoL was assessed by using the Medical Outcomes’ 36-Item Short Form Health Survey (SF-36) and the EuroQoL 5-dimension questionnaire (EQ-5D). All the assessments were performed before and after the 24-week treatment period. Results: A total of 20 CD patients were enrolled in this study from April to December 2011. CDIP-58 and CDQ-24 scores, which assess disease-specific HRQoL, showed a significant improvement after 24 weeks of treatment by botulinum toxin A (P < 0.001). However, EQ-5D and SF-36 scores, which assess general HRQoL, showed no significant improvement after the treatment (P > 0.05). Conclusion: CD patients’ disease-specific HRQoL improved after being treated with multiple botulinum toxin A injections. However, general HRQoL was not improved. |
format |
Journal |
author |
Kongsaengdao S. Maneeton B. Maneeton N. |
spellingShingle |
Kongsaengdao S. Maneeton B. Maneeton N. Quality of life in cervical dystonia after treatment with botulinum toxin a: A 24-week prospective study |
author_facet |
Kongsaengdao S. Maneeton B. Maneeton N. |
author_sort |
Kongsaengdao S. |
title |
Quality of life in cervical dystonia after treatment with botulinum toxin a: A 24-week prospective study |
title_short |
Quality of life in cervical dystonia after treatment with botulinum toxin a: A 24-week prospective study |
title_full |
Quality of life in cervical dystonia after treatment with botulinum toxin a: A 24-week prospective study |
title_fullStr |
Quality of life in cervical dystonia after treatment with botulinum toxin a: A 24-week prospective study |
title_full_unstemmed |
Quality of life in cervical dystonia after treatment with botulinum toxin a: A 24-week prospective study |
title_sort |
quality of life in cervical dystonia after treatment with botulinum toxin a: a 24-week prospective study |
publishDate |
2017 |
url |
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85010280708&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/40837 |
_version_ |
1681421891221323776 |